Quaker Chemical (NYSE:KWR) Stock Rating Upgraded by StockNews.com

Quaker Chemical (NYSE:KWR) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday.

Several other equities analysts also recently issued reports on KWR. Royal Bank of Canada dropped their price target on shares of Quaker Chemical from $195.00 to $180.00 and set an “outperform” rating for the company in a research note on Monday, November 4th. Piper Sandler upped their price target on Quaker Chemical from $190.00 to $200.00 and gave the company an “overweight” rating in a research report on Friday, November 8th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Quaker Chemical from $190.00 to $182.00 and set a “buy” rating on the stock in a research note on Monday, November 4th.

Quaker Chemical Stock Up 1.2 %

Shares of NYSE:KWR opened at $157.70 on Thursday. Quaker Chemical has a 52-week low of $151.31 and a 52-week high of $221.94. The company has a market capitalization of $2.81 billion, a PE ratio of 23.12, a price-to-earnings-growth ratio of 1.88 and a beta of 1.38. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.88 and a current ratio of 2.54. The company has a fifty day moving average of $163.01 and a 200-day moving average of $169.28.

Quaker Chemical (NYSE:KWR) last posted its earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 EPS for the quarter, missing the consensus estimate of $2.08 by ($0.19). The firm had revenue of $462.27 million during the quarter, compared to the consensus estimate of $469.17 million. Quaker Chemical had a net margin of 6.58% and a return on equity of 10.10%. Quaker Chemical’s revenue for the quarter was down 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.05 earnings per share. On average, equities analysts predict that Quaker Chemical will post 7.78 EPS for the current fiscal year.

Insiders Place Their Bets

In other Quaker Chemical news, EVP Jeewat Bijlani sold 645 shares of the firm’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $165.98, for a total value of $107,057.10. Following the completion of the sale, the executive vice president now directly owns 4,747 shares in the company, valued at approximately $787,907.06. This trade represents a 11.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP David Slinkman sold 1,700 shares of Quaker Chemical stock in a transaction on Monday, November 25th. The shares were sold at an average price of $167.80, for a total transaction of $285,260.00. Following the completion of the sale, the senior vice president now directly owns 2,825 shares of the company’s stock, valued at approximately $474,035. This trade represents a 37.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.30% of the company’s stock.

Institutional Trading of Quaker Chemical

Several large investors have recently made changes to their positions in the company. Harbor Capital Advisors Inc. grew its stake in Quaker Chemical by 112.8% in the third quarter. Harbor Capital Advisors Inc. now owns 8,903 shares of the specialty chemicals company’s stock valued at $1,500,000 after acquiring an additional 4,720 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Quaker Chemical by 3.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 108,122 shares of the specialty chemicals company’s stock valued at $22,193,000 after purchasing an additional 3,441 shares in the last quarter. Cerity Partners LLC raised its holdings in Quaker Chemical by 485.5% during the third quarter. Cerity Partners LLC now owns 64,631 shares of the specialty chemicals company’s stock worth $10,890,000 after buying an additional 53,592 shares during the last quarter. ProShare Advisors LLC lifted its stake in shares of Quaker Chemical by 68.3% in the second quarter. ProShare Advisors LLC now owns 67,812 shares of the specialty chemicals company’s stock valued at $11,508,000 after buying an additional 27,514 shares in the last quarter. Finally, Renaissance Technologies LLC grew its holdings in shares of Quaker Chemical by 37.4% during the second quarter. Renaissance Technologies LLC now owns 21,300 shares of the specialty chemicals company’s stock valued at $3,615,000 after buying an additional 5,800 shares during the last quarter. 77.46% of the stock is currently owned by institutional investors and hedge funds.

About Quaker Chemical

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.